Tuning the Extended Structure and Electronic Properties of Gold(I) Thienyl Pyrazolates
摘要:
A series of thienyl pyrazole proligands and gold(l) thienyl pyrazolate cyclic trinuclear complexes (CTCs) have been synthesized. The relationship between the structure and emission properties of bridging thienyl pyrazolates within gold(I) cyclic trinuclear complexes suggests that the nature of dual emission is sensitive to ligand conjugation length. Density functional theory has been used to support the assignment of metal-sensitized, ligand-localized phosphorescence from monothienyl complexes, while low-lying, ligand-localized LUMOs present in bithienyl systems prohibit metal-sensitized phosphorescence. Soluble n-hexyl derivatives have been synthesized to explore the electrochemical properties of gold(I) thienyl pyrazolates CTCs, and conductive electropolymerized thin films were realized.
2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
申请人:Kenda Benoît
公开号:US20090312333A1
公开(公告)日:2009-12-17
The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
申请人:UCB Pharma, S.A.
公开号:US08178533B2
公开(公告)日:2012-05-15
The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
申请人:UCB Pharma S.A.
公开号:EP2308870A2
公开(公告)日:2011-04-13
The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.